These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 12172764

  • 1. Reduction of plasma homocysteine by folic acid in children with chronic renal failure.
    Kang HG, Lee BS, Hahn H, Lee JH, Ha IS, Cheong HI, Choi Y.
    Pediatr Nephrol; 2002 Jul; 17(7):511-4. PubMed ID: 12172764
    [Abstract] [Full Text] [Related]

  • 2. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
    Kárpáti I, Balla J, Szóke G, Bereczky Z, Páll D, Ben T, Toma K, Katona E, Mohácsi A, Paragh G, Varga Z, Kakuk G, Muszbek L.
    Orv Hetil; 2002 Jul 07; 143(27):1635-40. PubMed ID: 12180000
    [Abstract] [Full Text] [Related]

  • 3. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.
    Dierkes J, Domröse U, Ambrosch A, Bosselmann HP, Neumann KH, Luley C.
    Clin Nephrol; 1999 Feb 07; 51(2):108-15. PubMed ID: 10069646
    [Abstract] [Full Text] [Related]

  • 4. Different doses of oral folic acid for homocysteine-lowering therapy in patients on hemodialysis: a randomized controlled trial.
    Ossareh S, Shayan-Moghaddam H, Salimi A, Asgari M, Farrokhi F.
    Iran J Kidney Dis; 2009 Oct 07; 3(4):227-33. PubMed ID: 19841527
    [Abstract] [Full Text] [Related]

  • 5. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
    Nerbass FB, Draibe SA, Feiten SF, Chiarello PG, Vannucchi H, Cuppari L.
    J Am Diet Assoc; 2006 Feb 07; 106(2):267-70. PubMed ID: 16442876
    [Abstract] [Full Text] [Related]

  • 6. Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate-advanced chronic renal failure.
    Bernasconi AR, Liste A, Del Pino N, Rosa Diez GJ, Heguilén RM.
    Nephrology (Carlton); 2006 Apr 07; 11(2):137-41. PubMed ID: 16669976
    [Abstract] [Full Text] [Related]

  • 7. Plasma homocysteine concentration changes after renal transplantation in children.
    Merouani A, Delvin EE, Genest J, Rozen R, Lambert M.
    Pediatr Nephrol; 2002 Jul 07; 17(7):520-3. PubMed ID: 12172766
    [Abstract] [Full Text] [Related]

  • 8. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M.
    Z Kardiol; 2004 Jun 07; 93(6):439-53. PubMed ID: 15252738
    [Abstract] [Full Text] [Related]

  • 9. Hyperhomocysteinemia in children on renal replacement therapy.
    Feinstein S, Sela BA, Drukker A, Becker-Cohen R, Raveh D, Gavendo S, Frishberg Y.
    Pediatr Nephrol; 2002 Jul 07; 17(7):515-9. PubMed ID: 12172765
    [Abstract] [Full Text] [Related]

  • 10. Treatment of hyperhomocysteinemia in children on dialysis by folic acid.
    Schröder CH, de Boer AW, Giesen AM, Monnens LA, Blom H.
    Pediatr Nephrol; 1999 Sep 07; 13(7):583-5. PubMed ID: 10460506
    [Abstract] [Full Text] [Related]

  • 11. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V, Kes P, Zeljko R, Kusec V.
    Acta Med Croatica; 2006 Jun 07; 60(3):201-8. PubMed ID: 16933832
    [Abstract] [Full Text] [Related]

  • 12. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM, Nguyen H, Gonin R, Sarna A, Michels A, Masri-Imad F, Bommareddy G, Chassaing C, Wainer I, Loya A, Cary D, Barker LF, Assefi A, Greenspan R, Mahoney D, Wilcox CS.
    J Nephrol; 2003 Jun 07; 16(4):522-34. PubMed ID: 14696754
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N, Hosseini RS, Atabak S, Nateghiyan N, Golestan B, Rad AH.
    Saudi J Kidney Dis Transpl; 2009 Sep 07; 20(5):779-88. PubMed ID: 19736473
    [Abstract] [Full Text] [Related]

  • 14. [Effects of folic acid supplementation on hyperhomocysteinemia in CAPD patients: effects on unsaturated fatty acids].
    Hirose S, Kim S, Matsuda A, Itakura Y, Matsumura O, Tamura H, Nagasawa R, Mitarai T, Isoda K.
    Nihon Jinzo Gakkai Shi; 1998 Jan 07; 40(1):8-16. PubMed ID: 9513377
    [Abstract] [Full Text] [Related]

  • 15. Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients.
    Righetti M, Ferrario GM, Milani S, Serbelloni P, La Rosa L, Uccellini M, Sessa A.
    Med Sci Monit; 2003 Apr 07; 9(4):PI19-24. PubMed ID: 12709680
    [Abstract] [Full Text] [Related]

  • 16. [The effect of lowering plasma homocysteine levels on some parameters of thrombotic activity in haemodialyzed patients with chronic renal failure].
    Kozłowska I.
    Ann Acad Med Stetin; 2004 Apr 07; 50(1):87-95. PubMed ID: 16871747
    [Abstract] [Full Text] [Related]

  • 17. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
    Vianna AC, Mocelin AJ, Matsuo T, Morais-Filho D, Largura A, Delfino VA, Soares AE, Matni AM.
    Hemodial Int; 2007 Apr 07; 11(2):210-6. PubMed ID: 17403173
    [Abstract] [Full Text] [Related]

  • 18. Homocysteine lowering with folic acid supplements in children: effects on blood pressure.
    Papandreou D, Malindretos P, Arvanitidou M, Makedou A, Rousso I.
    Int J Food Sci Nutr; 2010 Feb 07; 61(1):11-7. PubMed ID: 19939196
    [Abstract] [Full Text] [Related]

  • 19. Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation.
    Huemer M, Ausserer B, Graninger G, Hubmann M, Huemer C, Schlachter K, Tscharre A, Ulmer H, Simma B.
    Epilepsia; 2005 Oct 07; 46(10):1677-83. PubMed ID: 16190942
    [Abstract] [Full Text] [Related]

  • 20. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis.
    Malerba M, Gisondi P, Radaeli A, Sala R, Calzavara Pinton PG, Girolomoni G.
    Br J Dermatol; 2006 Dec 07; 155(6):1165-9. PubMed ID: 17107384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.